Cardiometabolic Syndrome

Cardiometabolic Syndrome is Epidemic.

3-of-5-is-metabolic-syndrom med hr

Making the diagnosis of cardiometabolic syndrome is straight forward and does not require expensive testing. The presence of any three of the above five conditions makes the diagnosis of cardiometabolic syndrome.

While diabetes is considered a heart attack risk equivalent, there are other vascular complications as shown in the above slide. Uncontrolled diabetes and untreated cardiometabolic syndome cause vascular damage that significantly impacts the lives of patients and cost of their medical care.

Cardiometabolic syndrome is a common condition that affects one-third of the US adult population (over 60 million Americans) and increases with age. Cardiometabolic syndrome is associated with cardiovascular disease and includes a constellation of risk factors such as central obesity, high blood pressure, insulin resistance, abnormal cholesterol levels, microalbuminuria and hypercoagulability. Collectively, these risk factors increase the utilization of expensive healthcare resources because of increased hospitalizations due to heart attack, stroke, congestive heart failure and chronic kidney disease. Cardiometabolic syndrome is associated with endothelial dysfunction, vascular inflammation, abnormal thrombolysis, and increased oxidative stress that accelerate progression of cardiovascular disease.

Cardiometabolic Center provides a team approach to this complex condition by a select group of independent, well trained and dedicated board certified medical specialists. Their collaborative efforts are aimed at achieving better patient outcomes and lower healthcare cost. Their concerted effort to reduce macrovascular complications such as heart attack, stroke and PAD, and microvascular complications such as kidney failure, blindness and neuropathy, result in fewer hospitalizations, disability and death. 

This diagram shows the complex interplay of many risk factors in cardiometabolic syndrome. Optimal treatment requires a collaborative approach involving the patient, primary care physician, preventive cardiologist - clinical lipidologist and diabetic specialist - endocrinologist.

© NJPCCC  2015